Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 2008 Feb 6;46(4):1435–1450. doi: 10.1128/JCM.02207-07

Multiple-Locus Variable-Number Tandem-Repeat Analysis as a Tool for Subtyping Listeria monocytogenes Strains

Katharine E Volpe Sperry 1,*, Sophia Kathariou 2, Justin S Edwards 1, Leslie A Wolf 1
PMCID: PMC2292909  PMID: 18256218

Abstract

Listeria monocytogenes, like many other food-borne bacteria, has certain strains that are commonly linked to outbreaks. Due to the relatively low numbers of affected individuals, outbreaks of L. monocytogenes can be difficult to detect. The current technique of molecular subtyping in PulseNet laboratories to identify genetically similar strains is pulsed-field gel electrophoresis (PFGE). While PFGE is state-of-the-art, interlaboratory comparisons are difficult because the results are highly susceptible to discrepancies due to even minor variations in experimental conditions and the subjectivity of band marking. This research was aimed at the development of a multiple-locus variable-number tandem-repeat analysis (MLVA) that can be implemented in PulseNet laboratories to replace or complement existing protocols. MLVA has proven to be a rapid and highly discriminatory tool for subtyping many bacteria. In this study, a novel MLVA method for L. monocytogenes strains was developed utilizing eight loci multiplexed into two PCRs. The PCR products were separated by capillary gel electrophoresis for high throughput and accurate sizing, and the fragment sizes were analyzed and clustered based on the number of repeats. When tested against a panel of 193 epidemiologically linked and nonlinked isolates, this MLVA for L. monocytogenes strains demonstrates strong epidemiological concordance. Since MLVA is a high-throughput screening method that is fairly inexpensive, easy to perform, rapid, and reliable, it is well suited to interlaboratory comparisons during epidemiological investigations of food-borne illness.


Listeria monocytogenes, the causative agent of listeriosis, is a dangerous food-borne pathogen. Listeriosis causes meningitis, encephalitis, and septicemia, primarily in the elderly or in immunocompromised patients. It is most severe, however, in pregnant women and neonates due to its ability to cross the placenta and infect the fetus, causing congenital defects, stillbirth, and miscarriage. L. monocytogenes is most commonly acquired through consumption of contaminated foods such as unpasteurized or incompletely pasteurized cheeses and ready-to-eat foods, especially deli-type meats, due to its ability to grow at 4°C and to contaminate the food-processing environment. Given the severity of L. monocytogenes infections and potentially tragic outcomes, improving the detection of outbreaks and the discriminatory power of molecular subtyping methods is clearly a priority for food safety initiatives (7, 48). Public health laboratory scientists and epidemiologists play a critical role in this initiative by subtyping food-borne bacteria and performing outbreak investigations.

Bacterial subtyping is used to determine the relatedness among different isolates as part of an epidemiologic investigation. PulseNet, the international molecular subtyping network for food-borne bacteria developed and managed by the Centers for Disease Control and Prevention (CDC), utilizes pulsed-field gel electrophoresis (PFGE) as one key method for early detection of strains linked to potential outbreaks. This subtyping method compares DNA fragment patterns generated by macrorestriction digests of total genomic DNA that are separated by electrophoresis. The resulting banding patterns are compared to determine similarity. When clusters of isolates with similar PFGE profiles are detected, public health laboratories share these data with the epidemiologists, who then perform food history investigations to track the source of the organism. PulseNet PFGE protocols have been standardized and disseminated to public health laboratories by the CDC (32). These protocols must be strictly followed to ensure that the results are comparable from laboratory to laboratory.

The CDC developed an international database so that PulseNet laboratories can submit normalized PFGE patterns, thus enabling interlaboratory comparisons. PulseNet laboratories use the patterns submitted to the database to detect clusters of cases, to identify increases in the occurrence of a specific subtype, and to identify outliers to an outbreak. Subtyping by PulseNet laboratories in concert with epidemiological investigations has in many cases identified and/or confirmed the source of an outbreak (50). At the end of 2006, the L. monocytogenes database consisted of a total of 7,753 gel images (tiff files) including 920 unique AscI patterns and 1,262 unique ApaI patterns. Since the inception of the L. monocytogenes database, 77 clusters have been identified including 17 outbreaks linked to likely sources (Steven G. Stroika, PulseNet National Database Team, CDC, Atlanta, GA, personal communication).

L. monocytogenes has many serotypes, although serotypes 1/2a, 1/2b, and 4b are implicated in most cases of human disease (20). Serotype 4b is responsible for the majority of outbreaks and has been shown to be highly clonal (11, 17). Among the outbreak strains of serotype 4b, two strain subtypes continually reemerge. These are known as epidemic clone I (ECI) and epidemic clone II (ECII). These clones have been responsible for many outbreaks within North America and Europe (23, 34, 54). Due to the clonal nature of L. monocytogenes, novel subtyping methods are required to accurately discriminate among these common strain types. The current method, PFGE, is very labor-intensive and somewhat subjective. PFGE also relies on computer-based band marking, which can be inaccurate and requires manual interpretation by trained personnel to identify clusters. In practice, even minor deviations in experimental conditions can produce pronounced differences in patterns. Significant differences in patterns can also be attributed to the presence of mobile genetic elements. Other methods developed to subtype L. monocytogenes strains include multilocus sequence typing (15, 44, 56) and suspension microarray analysis based on specific genes or single-nucleotide polymorphisms (8, 9, 21). These methods tend to be technically demanding and expensive although the data are portable and nonsubjective. Since these methods are based on DNA sequences, they are genetically relevant.

Multiple-locus variable-number tandem-repeat (VNTR) analysis (MLVA) is a proven, rapid, and highly discriminatory subtyping method for agents such as Bacillus anthracis, Francisella tularensis, and Escherichia coli (25, 28, 35, 36). This type of analysis has been successful because bacteria have highly variable repeated elements throughout their genomes. VNTRs are short segments of DNA that have hypervariable copy numbers. It is thought that the variation in copy number is due to slipped-strand mispairing during DNA polymerase mediated duplications or possibly due to recombination (51). Despite mutations that may occur within the tandem repeat, the unit length remains relatively constant while the copy number varies. The tandem repeats are in stable regions of the genome, and they are not likely to be associated with mobile genetic elements, such as plasmids. The difference in copy numbers at specific loci is used to measure relatedness of strains in this subtyping scheme. To date, only limited information is available on MLVA applications with L. monocytogenes. In a recently published study, six loci were employed to subtype 45 isolates. Most of the isolates included were serotype 1/2a; strains of serotypes 1/2b and 4b were not sufficiently represented in this study (40). The current research was aimed at the development of MLVA for L. monocytogenes strains that can be implemented in PulseNet laboratories to replace or complement existing protocols.

MATERIALS AND METHODS

Bacterial strains and nucleic acid extraction.

A total of 193 L. monocytogenes isolates were acquired from the culture collections at the CDC (Atlanta, GA), North Carolina State University (Raleigh, NC), North Carolina State Laboratory of Public Health ([NCSLPH] Raleigh, NC) (clinical specimens from 2001 to 2006), and the American Type Culture Collection (Manassas, VA) (Table 1). Many of the strains included have been described previously in the World Health Organization (WHO) international multicenter L. monocytogenes subtyping study as well as other publications (6, 10, 27).

TABLE 1.

L. monocytogenes isolate information

Serotype and isolate name Alternate name Strain information
Source and/or reference MLVA locus copy number
EGb Date/location Origin (type)c Lm-2 Lm-8 Lm-10 Lm-11 Lm-3 Lm-15 Lm-23 Lm-32
Serotype 1/2a
    G3965a TS-4/F6854 1 1988 Turkey franks (S) CDC; 3,6 16 3 5 1 1 2 32 14
    G3975a TS-14/F6900 1 1988 Clinical; turkey franks (S) CDC; 3,6 16 3 5 1 1 2 32 14
    G4013a TS-52/F7125 1 1988 Turkey franks (S) CDC; 3,6 16 3 5 1 1 2 32 14
    G4000 TS-39/F7390 3 1988-1990 Food (S) CDC; 6,43 16 3 5 1 1 2 32 14
    G4017 TS-56/F6801 3 1988-1990 Clinical (S) CDC; 6,43 16 3 5 1 1 2 32 14
    G4028 TS-67/F6953 3 1988-1990 Clinical (S) CDC; 6,43 16 3 5 1 1 2 32 14
    G4038 TS-77 3 1988-1990 Clinical (S) CDC; 6,43 16 3 5 1 1 2 32 14
    G3972 TS-11/F7249 10 1988-1990 Processing plant (S) CDC; 6,53 16 3 5 1 1 2 32 14
    G3976 TS-15/F7272 10 1988-1990 Processing plant (S) CDC; 6,53 16 3 5 1 1 2 32 14
    G3979a TS-18/F7222 10 1988-1990 Processing plant (S) CDC; 6,53 16 3 5 1 1 2 32 14
    G3981 TS-20/F7283 10 1988-1990 Processing plant (S) CDC; 6,53 16 3 5 1 1 2 32 14
    G3997a TS-36/F7228 10 1988-1990 Processing plant (S) CDC; 6,53 16 3 5 1 1 2 32 14
    G4010 TS-49/F7273 10 1988-1990 Processing plant (S) CDC; 6,53 16 3 5 1 1 2 32 14
    G4023 TS-62/F7294 10 1988-1990 Processing plant (S) CDC; 6,53 16 3 5 1 1 2 32 14
    G4029 TS-68/F7295 10 1988-1990 Processing plant (S) CDC; 6,53 16 3 5 1 1 2 32 14
    H8395a H7764 Food CDC 16 3 5 1 1 2 32 14
    J0161a 2000 Clinical; turkey (E) CDC; 42 16 3 5 1 1 2 32 14
    NC2001-021a J0335 2000/NC Clinical NCSLPH 16 3 5 1 1 2 32 14
    G3984a TS-23/L745 14 1981/England Clinical (E) CDC; 6,38 15 3 5 −2 1 2 20 13
    G3994a TS-33/L735 14 1981/England Clinical (E) CDC; 6,38 15 3 5 −2 1 2 20 13
    G4014 TS-53/L6483 23 Scotland Animal strain CDC; 6 16 3 5 4 1 2 27 13
    G4020 TS-59 Animal strain CDC 17 3 5 −2 5 2 39 13
    G4039 TS-78 23 Scotland Animal strain CDC; 6 17 3 5 −2 5 2 39 13
    G3991 TS-30/L5151 24 United Kingdom Clinical (S) CDC; 6 17 3 5 −2 6 2 39 13
    G4005 TS-44/L5669 24 United Kingdom Clinical (S) CDC; 6 17 3 5 −2 6 2 39 13
    EGDea BAA-679/ AL591824 ATCC; 29 18 3 5 4 4 2 19 13
    H2446a 1996 Clinical (S) CDC 15 3 5 −2 1 2 20 13
    H3281c Clinical CDC 15 3 5 5 1 2 20 13
    NC2001-025a J0303 2001/NC Clinical NCSLPH 16 3 5 −2 6 1 24 13
    NC2001-082 J0834 2001/NC Clinical NCSLPH 16 3 5 4 1 2 27 13
    NC2001-236a J1090 2001/NC Clinical NCSLPH 19 3 5 4 7 2 32 13
    NC2002-001a J1240 2002/NC Clinical NCSLPH 16 3 5 4 1 2 27 13
    NC2002-002a J2147 2002/NC Clinical NCSLPH 14 3 5 4 5 3 22 13
    NC2002-119a J1369 2002/NC Clinical NCSLPH 16 3 5 4 1 2 27 13
    NC2002-327a J2148 2002/NC Clinical NCSLPH 16 3 5 1 1 2 32 14
    NCAg2002-890a 2002/NC Deli meat NCSLPH 16 3 5 4 1 2 27 13
    NC2003-184a J2416 2003/NC Clinical NCSLPH 16 3 5 −2 6 2 35 13
    NC2004-363a J3009 2004/NC Clinical NCSLPH 17 3 5 −2 5 2 39 13
    NC2004-454 J3111 2004/NC Clinical NCSLPH 16 3 5 1 1 2 32 14
    NC2005-397 J3496 2005/NC Clinical NCSLPH 17 3 5 4 4 2 30 13
    NC2005-462 J3591 2005/NC Clinical NCSLPH 16 3 5 −2 3 1 18 13
    NC2005-513 J3620 2005/NC Clinical NCSLPH 16 3 5 −2 2 1 18 13
    NC2005-585 J3692 2005/NC Clinical NCSLPH 20 3 5 −2 3 2 20 13
    NC2006-644 J4244 2006/NC Clinical NCSLPH 16 3 5 −2 9 1 26 13
Serotype 1/2b
    G3967 TS-6/F7473 4 1988-1990 Clinical (S) CDC; 6,43 15 3 5 4 4 4 33 14
    G4019 TS-58/F7493 4 1988-1990 Food (S) CDC; 6,43 15 3 5 4 4 4 33 14
    G3978 TS-17/F7271 5 1988-1990 Clinical (S) CDC; 6,43 16 3 5 5 6 5 29 17
    G4022 TS-61/F7378 5 1988-1990 Food (S) CDC; 6,43 16 3 5 5 6 5 29 17
    G4009a TS-48/F7432 7 Clinicald (S) CDC; 6 16 3 5 5 3 4 35 13
    G4027a TS-66/F2433 7 Clinicald (S) CDC; 6 16 3 5 5 3 4 35 13
    G3985a TS-24/F7598 8 Clinicale (S) CDC; 6 16 3 5 5 3 4 35 13
    G4025a TS-64/F7599 8 Clinicale (S) CDC; 6 16 3 5 5 3 4 35 13
    G3964a TS-3/L4704 20 Clinical; soft cheese (S) CDC; 6,24 16 3 5 5 7 5 29 17
    G4008a TS-47/L4705 20 Soft cheese (S) CDC; 6,24 16 3 5 5 7 5 29 17
    G3966 TS-5/L5674 24 United Kingdom Clinical (S) CDC; 6 16 3 5 5 7 5 29 17
    G3977 TS-16/L5089 24 United Kingdom Clinical (S) CDC; 6 16 3 5 5 7 5 29 17
    G4007 TS-46/L6116 24 United Kingdom Clinical (S) CDC; 6 16 3 5 5 7 5 29 17
    G4598 Italy GEf; rice salad (E) CDC; 46 15 3 5 4 4 4 33 14
    G4599 Italy GEf; rice salad (E) CDC; 46 15 3 5 4 4 4 33 14
    G4600 Italy GEf; rice salad (E) CDC; 46 15 3 5 4 4 4 33 14
    G4601 Italy GEf; rice salad (E) CDC; 46 15 3 5 4 4 4 33 14
    G4602 Italy GEf; rice salad (E) CDC; 46 15 3 5 4 4 4 33 14
    G6003 1994/IL GEf; chocolate milk (E) CDC; 16 16 3 5 5 6 5 25 17
    G6004 1994/IL GEf; chocolate milk (E) CDC; 16 16 3 5 5 6 5 25 17
    G6005 1994/IL GEf; chocolate milk (E) CDC; 16 16 3 5 5 6 5 25 17
    H8393a 1994/IL GEf; chocolate milk (E) CDC; 16 16 3 5 5 6 5 25 17
    G6006a 1994/IL GEf; chocolate milk (E) CDC; 16 16 3 5 5 6 5 25 17
    G6054 1994/IL GEf; chocolate milk (E) CDC; 16 16 3 5 5 6 5 25 17
    G6055a 1994/IL GEf; chocolate milk (E) CDC; 16 16 3 5 5 6 5 25 17
    G6060 1994/IL GEf; chocolate milk (E) CDC; 16 16 3 5 5 6 5 25 17
    NC2003-123a J2326 2003/NC Clinical NCSLPH 12 3 6 5 4 −2 33 17
    NC2005-625 J3773 2005/NC Clinical NCSLPH 16 3 5 4 3 3 27 14
    NCAg2006-1396-1400 2006/NC Egg Salad NCSLPH 16 3 5 4 1 4 33 17
    NCAg2006-1429-1433 2006/NC Egg Salad NCSLPH 16 3 5 4 1 4 33 17
    NCAg2006-1434-1438 J4334 2006/NC Egg Salad NCSLPH 16 3 5 4 1 4 33 17
    NCAg2006-1477-1481 J4335 2006/NC Macaroni salad NCSLPH 16 3 5 4 1 4 33 17
    NCAg2006-1482-1486 J4336 2006/NC Sweet slaw NCSLPH 16 3 5 4 1 4 33 17
Serotype 1/2c
    G3963a TS-2/L4706 22 Clinicald (S) CDC; 6,38 19 3 5 4 6 2 19 13
    G3969a TS-8/L940 22 Clinicald (S) CDC; 6, 38 19 3 5 4 6 2 19 13
    G4018 TS-57/L4397 24 United Kingdom Clinical (S) CDC; 6 19 3 5 4 6 2 19 13
    G4041 TS-80 24 United Kingdom Clinical (S) CDC; 6 19 3 5 4 6 2 19 13
    NCSU2006-1 2006/NC Clinical NCSLPH 15 3 −2 4 6 2 23 13
Serotype 3b
    G3968a TS-7/G0039 6 Clinical (S) CDC; 6 16 3 5 5 6 5 29 17
    G3986a TS-25/G0141 6 Food (S) CDC; 6 16 3 5 5 6 5 29 17
    G4015 TS-54/G0145 6 Food (S) CDC; 6 16 3 5 5 6 5 29 17
    G4035 TS-74 6 Food (S) CDC; 6 16 3 5 5 6 5 29 17
    F6218 1988/CA Clinical (S) CDC; 6 15 4 7 5 1 3 33 18
    H1852 1996 Clinical (S) CDC 16 3 3 5 3 4 33 15
    H3288 Clinical CDC 16 3 7 3 5 4 19 17
Serotype 4?
    G3962 TS-1/L2772 24 United Kingdom Clinical (S) CDC; 6 15 3 3 5 1 5 23 17
Serotype 4b
    G3971 TS-10/F8353 2 1988-1990 Food (S) CDC; 6,43 15 3 3 5 1 5 23 17
    G3983 TS-22/F7954 2 1988-1990 Clinical (S) CDC; 6,43 15 3 3 5 1 5 23 17
    G3993 TS-32/F8070 2 1988-1990 Food (S) CDC; 6,43 15 3 3 5 1 5 23 17
    G4033 TS-72 2 1988-1990 Food (S) CDC; 6,43 15 3 3 5 1 5 23 17
    G3974a TS-13/F7440 9 Clinicale (S) CDC; 6 15 4 5 5 1 3 33 18
    G3989a TS-28/F7441 9 Clinicale (S) CDC; 6 15 4 5 5 1 3 33 18
    G3995a TS-34/F7439 9 Clinicale (S) CDC; 6 15 4 5 5 1 3 33 18
    G3996a TS-35/F5070 11 1983/MA Clinical; milk (E) CDC; 6,26 15 3 3 5 1 5 23 17
    G4003a TS-42/F1092 11 1983/MA Clinical; milk (E) CDC; 6,26 15 3 3 5 1 5 23 17
    G4036 TS-75 11 1983/MA Clinical; milk (E) CDC; 6,26 15 3 3 5 1 5 23 17
    G3990a TS-29/F2365 12 1985/LA Mexican-style cheese (E) CDC; 6,37 15 4 5 6 1 3 33 18
    H8394a 12 1985/LA Mexican-style cheese (E) CDC; 6,37 15 4 5 6 1 3 33 18
    G4002 TS-41/G3129 12 1985/LA Clinical; Mexican-style cheese (E) CDC; 6,37 15 4 5 6 1 3 33 18
    G4004a TS-43/F4565 12 1985/LA Clinical; Mexican-style cheese (E) CDC; 6,37 15 4 5 6 1 3 33 18
    G4037 TS-76 12 1985/LA Clinical; Mexican-style cheese (E) CDC; 6,37 15 4 5 6 1 3 33 18
    G3988a TS-27/L4738 13 1981/Nova Scotia Clinical; coleslaw (E) CDC; 6,47 15 4 5 5 1 3 33 18
    G4011a TS-50/L4760 13 1981/Nova Scotia Coleslaw (E) CDC; 6,47 15 4 5 5 1 3 33 18
    G4040 TS-79 13 1981/Nova Scotia Clinical; coleslaw (E) CDC; 6,47 15 4 5 5 1 3 33 18
    G3992a TS-31/L4491e 15 1976/France Clinical (E) CDC; 6,12 15 4 5 5 1 3 33 18
    G4030a TS-69/L4491a 15 1976/France Clinical (E) CDC; 6,12 15 4 5 5 1 3 33 18
    G3982a TS-21/L4486j 16 1987/Switzerland Cheese (E) CDC; 5,6 15 4 5 5 1 3 33 18
    G4016a TS-55/L4486a 16 1987/Switzerland Clinical; cheese (E) CDC; 5,6 15 4 5 5 1 3 33 18
    G4021a TS-60/4486b 16 1987/Switzerland Clinical; cheese (E) CDC; 5,6 15 4 5 5 1 3 33 18
    G4032 TS-71 16 1987/Switzerland Clinical; cheese (E) CDC; 5,6 15 4 5 5 1 3 33 18
    G3973a TS-12/L2192 17 1988/United Kingdom Clinical; goat cheese (S) CDC; 1,6 15 4 5 6 1 3 33 18
    G4001a TS-40/L2190a 17 1988/United Kingdom Goat cheese (S) CDC; 1,6 15 4 5 6 1 3 33 18
    G3980a TS-19/L1323 18 England Soft cheese (S) CDC; 2,6 15 4 5 5 1 3 33 18
    G3998a TS-37/L1327 18 England Clinical; soft cheese (S) CDC; 2,6 15 4 5 5 1 3 33 18
    G3999a TS-38/L3306 19 1988-1990/United Kingdom Clinical; pâté (E) CDC; 6,39 15 3 3 5 1 5 23 17
    G4006a TS-45/L3350 19 1988-1990/United Kingdom Pâté (E) CDC; 6,39 15 3 3 5 1 5 23 17
    G3970 TS-9/L4704 21 Alfalfa (S) CDC; 6,24 15 4 5 5 1 3 33 18
    G4024 TS-63/L4706 21 Clinical; alfalfa (S) CDC; 6,24 15 4 5 5 1 3 33 18
    G4034 TS-73 21 Clinical; alfalfa (S) CDC; 6,24 15 4 5 5 1 3 33 18
    G4031 TS-70 CDC 15 3 3 5 1 5 23 17
    Li2a 19115/ A52868/ A52869 ATCC 15 3 3 5 1 5 23 17
    H2444 1996 Clinical (S) CDC 12 3 5 5 1 3 19 17
    H3396 1997 Clinical (S) CDC 12 3 5 5 1 3 19 17
    H6383 1996 Clinical (S) CDC 12 3 5 5 1 3 19 17
    H7550a 1998 Clinical; hot dogs (E) CDC; 13 12 3 5 5 1 3 42 17
    H7596a 1998 Hot dogs (E) CDC; 13 12 3 5 5 1 3 42 17
    H7762a 1998 Hot dogs (E) CDC; 13 12 3 5 5 1 3 42 17
    H7969a 1998 Hot dogs (E) CDC; 13 12 3 5 5 1 3 42 17
    J1735 2002 Clinical; deli meat (E) CDC; 30 12 3 5 5 1 3 19 17
    J1815 2002 Environmental; deli meat (E) CDC; 30 12 3 5 5 1 3 19 17
    J1925 2002 Deli meat (E) CDC; 30 12 3 5 5 1 3 19 17
    J1838 2002/NJ Clinical (E) CDC; 30 12 3 5 5 1 3 25 17
    J2206 2003/NJ Clinical (S) CDC 12 3 5 5 1 3 19 17
    J2213 2003/AZ Clinical (S) CDC 15 4 5 5 1 3 33 18
    J2230 2003/MA Clinical (S) CDC 12 3 5 5 1 3 42 17
    J2255 2003/GA Clinical (S) CDC 15 3 3 5 2 5 31 11
    J2269 2003/GA Clinical (S) CDC 16 3 5 5 6 5 29 17
    J2275 2003/PA Clinical (S) CDC 15 4 5 5 1 3 33 18
    J2282 2003/MD Clinical (S) CDC 15 4 5 5 1 3 33 18
    J2288 2003/TX Clinical (S) CDC 15 4 7 5 1 3 33 18
    J2302 2003/CA Clinical (S) CDC 15 4 5 5 1 3 33 18
    J2313 2003/TX Clinical (S) CDC 15 4 7 5 1 3 33 18
    J2327 2003/MI Clinical (S) CDC 15 4 5 5 1 3 37 18
    J2353 2003/IL Clinical (S) CDC 15 4 5 5 1 3 33 18
    J2391 2003/TX Clinical; Mexican-style cheese (S) CDC 15 4 7 5 1 3 33 18
    J2422 2003/RI Clinical (S) CDC 15 3 9 4 2 5 27 17
    J2433 Mexican-style cheese CDC 15 4 7 5 1 3 33 18
    J2446 2003/OH Clinical (S) CDC 12 3 5 5 1 3 42 17
    J2479 2003/MI Clinical (S) CDC 11 3 5 5 −2 2 34 −2
    J2571 2003/KY Clinical (S) CDC 12 3 5 −2 −2 2 33 −2
    J2584 2003/VT Clinical (S) CDC 15 4 5 5 1 3 33 18
    J2621 2003/OR Clinical (S) CDC 15 3 5 5 2 3 15 17
    J2685 2004/NY Clinical (S) CDC 12 3 5 5 1 3 19 17
    J3006 2004/TX Clinical (S) CDC 12 3 5 5 1 3 19 17
    J3033 2004/IL Clinical (S) CDC 12 3 5 5 1 3 19 17
    J3200 2004/CT Clinical (S) CDC 12 3 5 5 1 3 25 17
    J3238 2004/NY Clinical (S) CDC 12 3 5 5 1 3 25 17
    J3558 2005/GA Clinical (S) CDC 15 4 5 5 1 3 33 18
    NC2001-004a J0247 2001/NC Clinical NCSLPH 16 3 5 5 1 4 33 17
    NC2001-006a J0246 2001/NC Clinical NCSLPH 16 3 5 5 1 4 33 17
    NC2001-007a J0245 2001/NC Clinical NCSLPH 15 3 3 5 3 4 25 17
    NC2001-008a J0244 2001/NC Clinical NCSLPH 15 3 3 5 3 4 25 17
    NC2001-075a J0835 2001/NC Clinical NCSLPH 11 3 5 5 −2 2 27 −2
    NC2001-126a J0833 2001/NC Clinical NCSLPH 12 3 5 5 1 3 34 17
    NC2001-182a J0927 2001/NC Clinical NCSLPH 15 4 5 5 1 3 33 14
    NC2003-151a J2339 2003/NC Clinical NCSLPH 11 3 5 5 −2 −2 36 −2
    NC2003-173a J2415 2003/NC Clinical NCSLPH 15 3 7 4 3 3 27 17
    NC2003-196a J2470 2003/NC Clinical NCSLPH 15 3 5 5 1 5 33 17
    NC2003-289a J2599 2003/NC Clinical NCSLPH 11 3 5 −2 −2 2 28 −2
    NC2003-332a J2638 2003/NC Clinical NCSLPH 15 4 5 5 1 3 33 18
    NC2004-271-273a J2932 2004/NC Clinicale NCSLPH 16 3 5 5 1 4 33 17
    NC2004-287a J2933 2004/NC Clinical NCSLPH 15 4 5 5 1 3 33 18
    NC2004-445-446a J3061 2004/NC Clinicald NCSLPH 16 3 5 5 1 4 33 17
    NC2004-471 J3112 2004/NC Clinical NCSLPH 15 3 7 5 2 4 33 18
    NC2004-643 J3219 2004/NC Clinical NCSLPH 15 3 7 5 1 3 33 17
    NC2005-062 J3294 2004/NC Clinical NCSLPH 15 3 5 5 1 3 15 21
    NC2005-446 J3552 2005/NC Clinical NCSLPH 15 4 5 5 1 3 33 18
    NC2005-490 J3590 2005/NC Clinical NCSLPH 12 3 5 5 1 3 40 17
    NC2005-681 J3825 2005/NC Clinical NCSLPH 15 4 5 5 1 3 33 18
    NC2006-296 J3982 2006/NC Clinical NCSLPH 15 3 3 5 3 4 25 17
    NCSU-34-2b 2003/NC Processing plant S. Kathariou; 22 12 3 5 5 1 3 40 17
    NCSU-34-6a 2003/NC Processing plant S. Kathariou 12 3 5 5 1 3 25 17
Serotype 4bx
    G4012a TS-51/L3334 19 1988-1990/United Kindgom Pâté (E) CDC; 6,39 15 3 3 5 1 5 23 17
    G4026a TS-65/L3238 19 1988-1990/United Kindgom Clinical; pâté (E) CDC; 6,39 15 3 3 5 1 5 23 17
Serotype 4c
    NC2006-612 J4245 21 2006/NC Clinical NCSLPH 11 3 5 −2 −2 2 30 −2
Serotype 4d
    G3987a TS-26/L4742 13 1981/Nova Scotia Clinical; coleslaw (E) CDC; 6,47 15 4 5 5 1 3 33 18
a

Seventy nine isolates used to determine subtyping ability.

b

EG are based on a WHO study (6).

c

S, sporadic; E, epidemic. If the food vehicle is known, it is given after the semicolon.

d

Multiple isolates from the same patient.

e

Grouped isolates from mothers and babies.

f

GE, gastroenteritis outbreak.

Each isolate was streaked for isolation and grown on 5% sheep blood agar (BBL blood agar base [infusion agar]; BD, Franklin Lakes, NJ) at 35°C overnight. Cultures were preserved using a Microbank cryo-preservation system (Pro-Lab Diagnostic, Austin, TX), per the manufacturer's directions, and stored at −70°C. Multiple methods for nucleic acid preparation were used. A loopful (using a sterile calibrated 1-μl inoculating loop) of pure bacterial growth was used for all methods. The MLVA protocol utilized the “boil prep” method (28, 35). Briefly, the bacteria were suspended in 100 μl of sterile nuclease-free H2O (Amresco, Solon, OH); the suspension was boiled at 95 to 100°C for 10 min and immediately chilled on ice to aid in cell lysis. Cell suspensions were centrifuged at 8,000 × g for 10 min to separate cellular debris. The clarified supernatant was used in the PCR. During initial development and for nucleic acid sequencing, DNA was extracted using a DNeasy Tissue kit (Qiagen, Valencia, CA) or MagNA Pure LC DNA Isolation III kit (Roche, Indianapolis, IN) per the manufacturer's directions for gram-positive organisms. Extracted DNA was stored at −20°C.

PFGE.

All PFGE was performed using PulseNet standardized procedures with Asc1 and Apa1 restriction enzymes (www.cdc.gov/pulsenet/protocols.htm) (32). Many of the PFGE patterns were downloaded from the PulseNet international database. The PFGE patterns that could not be acquired from the PulseNet database were analyzed by NCSLPH's PulseNet laboratory. Analysis was performed using BioNumerics (Applied Maths, Austin, TX) cluster analysis. The average from experiments was used to cluster the similarity matrix determined by each single enzyme analysis (AscI and ApaI) using the Dice coefficient with a 1.5 tolerance and the unweighted pair group method with arithmetic mean (UPGMA).

Genome analysis and primer design.

The two fully sequenced L. monocytogenes genomes, EGDe (accession number AL591824) (29) and F2365 (AE017262) (41), were used for analysis of tandem repeats. The two genomes were initially scanned individually using the Tandem Repeat Finder program (http://tandem.bu.edu/trf/trf.html) (4). The Genomes, Polymorphism and Minisatellites strain comparison page in the Microorganisms Tandem Repeat Database(http://minisatellites.u-psud.fr/) was then used to scan and compare both genomes (18, 19, 52). Primers were designed utilizing Primer3 software (http://frodo.wi.mit.edu/) (45). Each primer was designed in the flanking region of the tandem repeat to produce a fragment size no larger than 600 bp. Primers were synthesized by Proligo (Boulder, CO) and Integrated DNA Technologies (Coralville, IA). For fragment analysis, the forward primers were labeled with one of three WellRed dye-labeled phosphoramidites (D2, D3, and D4) and purified by high-performance liquid chromatography.

PCR amplification and fragment analysis.

Initial analysis of each locus was performed utilizing QuantiTect Sybr Green PCR (Qiagen, Valencia, CA) per the manufacturer's instructions on an iQ iCycler (Bio-Rad, Hercules, CA) with 0.3 μM unlabeled primer and 2 μl of DNA in 25-μl reaction mixtures; the PCR program consisted of 35 cycles, annealing at 50°C, and melt curve analysis. Standard PCR was performed per the manufacturer's directions using HotStar Taq polymerase (Qiagen, Valencia, CA), 0.3 μM of each primer, and 2 μl of DNA in 25-μl reaction mixtures; the PCR program consisted of 35 cycles and annealing at 50°C. Initial multiplexed PCR used a Multiplex PCR kit (Qiagen, Valencia, CA) per the manufacturer's instructions with 0.3 μM of each labeled primer (Table 2) and 2 μl of DNA in 25-μl reaction mixtures; the PCR program consisted of 35 cycles and annealing at 50°C. The finalized protocol consisted of two multiplexed PCRs (R1 and R2), each with four primer sets (concentrations are given in Table 2) using 1.5 U of Platinum Taq DNA polymerase, 2 mM MgCl2, 0.2 mM of the deoxynucleoside triphosphates, 1× PCR buffer, PCR-grade water (Invitrogen, Carlsbad, CA), and 1 μl of DNA in 10-μl reaction mixtures. The cycling conditions used were as follows: 95°C for 5 min and 35 cycles of 94°C for 20 s, 50°C for 20 s, and 72°C for 20 s, followed by one cycle of 72°C for 5 min and an indefinite hold at 4°C on an MJF Tetrad (Bio-Rad, Hercules, CA) (28).

TABLE 2.

MLVA Primers for L. monocytogenes

PCR and VNTR locus Dyea Forward primer (5′-3′) Reverse primer (5′-3′) Final conc (μM)
R1
    Lm-2 D4 CGTATTGTGCGCCAGAAGTA CAGCAACGCAACAACAAACAG 0.1
    Lm-8 D2 ACGCGCAATACTATAAAGGGTGTC AGAAAAAGCGGAAGCAGATAAGAA 0.2
    Lm-10 D3 CAGATATCGATACGATTGAC CAGTTAGTATTTCCAACGTC 0.35
    Lm-11 D3 GAATAAAATGCTAGATGTGG CCGATTCAAAAATAGTAAAC 0.15
R2
    Lm-3 D4 CAAACCGAGATGGTGTAGCA TGGTTTTGATGGATCAACTGG 0.05
    Lm-15 D2 GGACTTAACGAATACAAAAG GCTGTTACAAGTAAAACTGG 0.15
    Lm-23 D4 TATTTACGGAAAAGACGTAG CGTAACTGTCCTACCATTAG 0.1
    Lm-32 D3 AAAGCTTTGCCAGTGCAAGT TTGTGACTTGGCACTTCTGG 0.25
a

WellRed phosphoramidite dye label attached to the 5′ end of forward primer.

Fragments were sized by combining 1 μl of a 1:60 dilution of the PCR product with 20 μl of deionized formamide (sample loading solution) and 0.08 μl of DNA size standard 600 (Beckman Coulter, Fullerton, CA) (9, 28). Fragment analysis was performed on a Beckman Coulter CEQ 8000 genetic analyzer (Beckman Coulter, Fullerton, CA) using the Frag-Test method, and fragments were analyzed with default fragment analysis parameters edited to reflect the DNA size standard 600 and quartic model (28). Estimated fragment size, peak height, and dye for each isolate were exported in comma-delimited format (.cvs) and imported in BioNumerics (Applied Maths, Austin, TX). Customized scripts were developed by Applied Maths (Austin, TX) and are available at www.applied-maths.com. These scripts are used to import the fragment sizes (VNTRimport_v3) and to calculate copy numbers (VNTRcalc). Null alleles were coded as negative. UPGMA cluster analysis of copy number was performed with a categorical multistate coefficient.

Sequence verification.

The loci and flanking regions were amplified with HotStar Taq Polymerase (Qiagen, Valencia, CA) as described above. The PCR products were purified using the QIAquick PCR Purification kit (Qiagen, Valencia, CA). Cycle sequencing was performed per the manufacturer's directions with the CEQ DTCS (dye terminator cycle sequencing) Quick Start kit (Beckman Coulter, Fullerton, CA) using 0.2 μM primer and 25 to 100 fmol of template DNA. Unincorporated dye terminators were removed with the DyeEx 2.0 spin kit (Qiagen, Valencia, CA) using an additional wash step of 300 μl of sterile nuclease-free sequence grade water (Amresco, Solon, OH) prior to the application of the sample or by using Clean Seq (Agencourt Biosciences, Beverly, MA) per the manufacturer's instructions. All samples were run on the CEQ 8000 genetic analyzer (Beckman Coulter, Fullerton, CA) using the LFR-1 method and default sequence analysis parameters.

Stability and reproducibility determinations.

Two L. monocytogenes strains, EGDe and Li2 (ATCC, Manassas, VA), were chosen for the stability study. Each was passaged on sheep blood agar plates 45 times, approximately 3 times per week. Samples were boiled as described previously at each passage. Ten evenly spaced isolates were tested by MLVA to determine the stability of each locus.

Reproducibility of the assay was determined by testing 100 isolates via the two multiplexed PCRs. This analysis was performed in triplicate on three different runs by two technicians.

RESULTS AND DISCUSSION

Identification of suitable loci.

A total of 75 tandem repeats were identified within the two fully sequenced genomes of L. monocytogenes (EGDe and F2365). Forty-three of these repeated elements that were under 600 bp in total length and had a unit length of 3 to 21 bp (Table 3) were analyzed. Initial screening of the loci was performed in a pilot study with a panel of 10 isolates consisting of two L. monocytogenes isolates, representing each of the following serotypes: 1/2a, 1/2b, 1/2c, 3b, and 4b. This pilot study of all loci was performed using Sybr green PCR with unlabeled primers for rapid and inexpensive preliminary screening. To ensure accurate amplification, primers where redesigned as needed.

TABLE 3.

All loci examined

VNTR locus (Lm) Reason for exclusiona Identification in strain EGDeb
Identification in strain F2365b
Comment (reference)
Location (nt) Locus tag (lmo) Location (nt) Locus tag (LMOf2365)
1 VFR 159184-159239 0159 168482-168437 0174
2 IU 619313-619457 0582 626060-626186 0611
3 IU 881561-881690 0842 881681-881756 0859 LM-TR-1 (40)
4 VFR 1171166-1171425 1136 1150533-1150708 1144 LM-TR-3, LM-TR-5 (40)
5 FAS 1315205-1315275 1289 ND ND LM-TR-6 (40)
8 IU 2016006-2016236 1941 1997109-1997354 1970 Overlap with Lm-9, Lm-36
10 IU ND ND 234028-234127 0231 LM-TR-4 (40)
11 IU 344972-345002 0320 358075-358150 0338
12 LD 426092-426116 NC 0402/043 N/D ND
13 LD ND ND 473899-473987 0450
14 LD 498894-499103 0460 515502-515689 0495
15 IU 668815-668859 0627 675532-675588 0656
16 LD ND ND 4B661176-661207 0643
17 LD 912002-912032 0872 ND ND
18 LD 1084362-1084389 NC 1055/1056 1085094-1085121 NC 1076/1077
19 LD 1109362-1109397 1077 ND ND
20 VFR 1163213-1163250 1129 ND ND
21 LD 1674419-1674448 1632 (trpG) 1652787-1652816 1654
22 LD 1821786-1821825 1752 ND ND
23 IU ND ND 1849586-1849694 NC 1825/1826 Overlap with Lm-6, Lm-7, Lm-35
24 LD 2229537-2229561 2144 ND ND
25 MB 2390349-2390507 2312 ND ND
26 LD 2169162-2169208 NC 2089/2090 2157801-2157867 NC 2121/2122 Overlap with Lm-37, LM-TR-2 (40)
27 VFR ND ND 2407116-2407160 2347
28 LD ND ND 386518-386530 NC 0361/0362
29 FAS ND ND 510256-510273 0492
30 LD ND ND 512407-512437 NC 0493/0494
31 LD 907377-907434 0866 907466-907491 0884
32 IU 1317290-1317361 1290 1297917-1298018 1307
33 LD 1318139-1318186 1291 1298796-1298855 1308
34 FAS 1706118-1706142 NC 1656/1657 1683878-1683950 NC 1677/1678
38 LD in 4b 2682706-2682722 2778 2631575-2631585 NC 2655/2567
39 LD in 4b 161183-161252 0160 170379-170475 0175
40 VFR 173499-173536 0175 178838-178893 0186
41 SNI 361132-361199 0333 376005-376063 0350
42 SNI 1748203-1748237 NC 1682/1683 1729244-1729287 NC 1706/1707
43 SNI 2264184-2264205 2178 2259418-2259445 2211
a

IU, locus in use; LD, low diversity; VFR, variability in flanking region; SNI, subtyping ability not improved; FAS, failed to amplify serotypes 1/2b, 3b, and 4b; MB, multiple band/peak products.

b

nt, nucleotide; NC, noncoding region, located between locus tags; ND, not detected by tandem-repeat database.

The Genomes, Polymorphism and Minisatellites website allowed us to compare the tandem repeats found within the two fully sequenced genomes. Some of the tandem repeats found individually in each of the genomes were, in fact, the same or overlapping. This was seen with Lm-8, Lm-9, and Lm-36; Lm-6, Lm-7, Lm-23, and Lm-35; and Lm-26 and Lm-37. The 37 remaining loci were tested on an expanded panel of 79 isolates (Table 1) with labeled primers using capillary electrophoresis fragment analysis to determine subtyping ability. The tandem repeats that did not produce accurate and reproducible results within the serotypes causing the majority of human illness (1/2a, 1/2b, and 4b) were eliminated from the study (Table 3). Lm-5, Lm-29, and Lm-34 were eliminated for their failure to amplify serotypes 1/2b, 3b, and 4b (Table 3).

In order to verify that the size determined by fragment analysis was indeed due to a change in repeat number and not to other genetic events, such as insertions and deletions, sequence analysis of both DNA strands was performed. For each locus, two isolates of each different allele size identified were sequenced. When necessary, primers were redesigned to provide more consistent sequencing results (data not shown). Sequence analysis showed that Lm-1, Lm-4, Lm-20, Lm-25, Lm-27, and Lm-40 had variability in the flanking regions that could not be avoided even with primer redesign. The variability included insertions and deletions that produced a change in fragment size that was not due to variations in repeat number. Since the sequence variability is not related to the tandem repeat, these loci were eliminated from this study. Loci that had very low diversity or did not affect subtyping ability were also eliminated (Table 3). Thus, a total of eight loci (Lm-2, Lm-3, Lm-8, Lm-10, Lm-11, Lm-15, Lm-23, and Lm-32) remained in this study.

Two of these loci, Lm-3 and Lm-10, were identified independently by Murphy et al. (LM-TR-1 and LM-TR-4) (40). In our study we also independently identified the other four loci described previously (40). These four loci were not chosen for inclusion in our L. monocytogenes MLVA for several reasons. Lm-5 (LM-TR-6) did not amplify serotypes 1/2b, 3b, and 4b, while Lm-26 (LM-TR-2) was found to have very low diversity. Genomic analysis showed that the other two loci (LM-TR-3 and LM-TR-5) overlapped. These tandem repeats were equivalent to our Lm-4, which was eliminated from the study due to sequence variability in the flanking region, possibly due to the overlapping repeat and not to a difference in copy number within the tandem repeat.

Assay development.

Eight of the remaining tandem repeats provided adequate diversity and were thoroughly evaluated with all 193 isolates (Table 1) for their ability to subtype these strains into epidemiologically significant clusters. Partial repeats were seen in Lm-10 and Lm-23. In all cases, these resulted in half of a repeat. For the purpose of analysis in BioNumerics, the allele size was changed from 12 to 6 and 6 to 3, respectively, to account for these half-repeats. In some instances no amplification was observed at a particular locus. Lack of amplification (a null allele) could be due to mutation at the primer site resulting in no PCR product. Since a null allele is different from a locus having zero repeats, it is denoted as −2 by BioNumerics (Table 4). Null alleles were observed in Lm-3, Lm-11, and Lm-32.

TABLE 4.

L. monocytogenes VNTR Loci

VNTR locus Unit length (bp) Allele range (copy no.) Offset (bp)c Repeat Diversity (%)d Locus tag Protein description or function
Lm-2 6 11-20 294 TTGTAT 68.8 lmo0582 P60 extracellular protein; invasion associated protein
Lm-3 9 1-9 (−2)b 203 TAAAACCTA 56.8 lmo0842 Cell wall surface anchor family protein
Lm-8 15 3-4 187 CAGCTTTCTCAGCAG 33.8 lmo1941 lysM domain protein
Lm-10 12 (6)a 3-9 315 GAAGAACCAAAA 29.4 lmo0220 ATP-dependent metalloprotease FtsH
Lm-11 12 1-6 (−2)b 103 TTGCTTGTTTTTG 60.4 lmo0320 Cell wall surface anchor family protein
Lm-15 12 1-7 321 CAAAAGATACAC 74.6 lmo0627 Cell wall surface anchor family protein
Lm-23 6 (3)a 15-42 164 CATCGG 84.5 lmo1799 Putative peptidoglycan bound protein (LPXTG motif)
Lm-32 6 13-21 (−2)b 84 AACACC 74.2 lmo1290 Hypothetical protein
a

Half-unit lengths used to compensate for partial alleles observed.

b

Null alleles, interpreted by the BioNumerics program as a copy number of −2, are possible at this locus.

c

Size of the fragment with no tandem repeats.

d

Simpson's index of diversity (based on 193 isolates tested) is calculated as follows: [1 − Σ(allele frequency2)] × 100, where the allele frequency is the number of times a particular allele appears/total number of strains tested.

A multiplexed PCR protocol was developed for these eight loci consisting of two reactions with four loci in each (Fig. 1). This assay was made to be concordant with the protocols previously developed for PulseNet laboratories to subtype E. coli and Salmonella enterica serotype Typhimurium (9, 28). To determine subtyping capabilities, the complete panel of 193 isolates consisting of both known outbreak and sporadic strains and including isolates from each of the serotypes of interest was analyzed (Table 1). The Simpson's index of diversity (49) for the eight tandem repeats ranged from 33.8% to 84.5% (Table 4). Based on the complete panel of isolates and the 54 unique MLVA profiles they produced, the calculated Simpson's index of diversity for the assay is 94%.

FIG. 1.

FIG. 1.

Listeria monocytogenes MLVA. Two multiplex PCRs including four loci each were analyzed on the CEQ 8000 (Beckman Coulter). Red peaks, size standard 600; black peaks, Lm-8, Lm-15 and Lm-23; green peaks, Lm-10, Lm-11, and Lm-32; blue peaks, Lm-2 and Lm-3. Multiplex PCR R1 is shown in the top panel, and R2 is shown in the bottom panel. nt, nucleotide.

The stability of each locus was evaluated to determine the effect of laboratory passage. All fragment sizes varied by less than ±1 bp (0.02 bp to 0.88 bp), indicating that these loci are stable during routine laboratory manipulation. The multiplexed MLVA was shown to be reproducible by determining the copy number for each locus on a panel of 100 isolates. Although the fragment sizes showed slight variation (less than ±1 bp), the copy number was determined to be 100% reproducible (data not shown).

Comparative effectiveness of MLVA and select other methods.

Copy numbers as determined by BioNumerics of all 193 isolates are shown in Table 1. A panel of 123 isolates (Table 1) was analyzed by this multiplexed MLVA and compared to PFGE (AscI and ApaI). Cluster analysis of these isolates reveals that MLVA efficiently separates isolates of genomic division 1 (lineage II) (serotypes 1/2a and 1/2c) from those of genomic division 2 (lineage I) (serotypes 1/2b, 3b, 4b, and a single isolate of 4d) (Fig. 2). Only a single clinical isolate of serotype 4c was available and was not included in the cluster analysis; however, the MLVA type is indicated in Table 1. The clear differentiation between the major genomic divisions (lineages) was in agreement with similar findings from numerous other subtyping approaches (for a review, see references 8, 10, 17, 44, 55, and 56).

FIG. 2.

FIG. 2.

Cluster analysis of 123 L. monocytogenes isolates based on MLVA type using the categorical coefficient and UPGMA. Genomic divisions are denoted as follows: •, genomic division 1 (serotypes 1/2a and 1/2c); ▪, genomic division 2 (serotypes 1/2b and 3b); ⧫, genomic division 2 (serotype 4b). The EC group is indicated if known.

Comparisons of MLVA and PFGE techniques can be quite difficult since they evaluate different types of genetic events. While PFGE relies on changes in the restriction enzyme site, MLVA relies on copy number changes of tandem repeats. Both are successful in grouping closely related and differentiating unrelated L. monocytogenes strains. PFGE and MLVA comparisons were performed by separating the isolates into groups based on serotype.

Although the MLVA and PFGE techniques clustered this diverse set of isolates differently, the results were very similar. Seven unique profiles were produced for 32 1/2a and 1/2c isolates examined by MLVA (Fig. 3A), while PFGE (AscI and ApaI) (Fig. 3B) produced 11 unique profiles based on cluster analysis in BioNumerics. These different profiles were in some cases due to one- or two-band differences. For instance, several strains (Fig. 3B, filled circles) exhibited a one-band difference in the ApaI pattern. The strains with this profile included isolate J0161 from the 2001 multistate outbreak as well as food, clinical, and environmental isolates implicated in listeriosis cases from 1988 to 1990. Epidemiological studies have revealed that these isolates are associated with the same food processing plant and likely represent long-term contamination of that facility with the same strain (42). Lastly, this cluster also includes two clinical isolates from North Carolina (NC2002-327 and NC2004-454, isolated in 2002 and 2004, respectively) which were indistinguishable by PFGE, suggesting that this strain type continues to circulate in food.

FIG. 3.

FIG. 3.

Cluster analysis of 32 L. monocytogenes serotype 1/2a and 1/2c isolates. Symbols next to isolate names indicate similar isolates in MLVA and PFGE dendrograms. If isolates have indistinguishable patterns, then they are listed with one representative pattern. (A) Results of MLVA typing using the categorical coefficient and UPGMA. (B) Results of two-enzyme PFGE analysis (AscI and ApaI). The average from experiments was used to cluster the similarity matrix determined by single-enzyme analysis using the Dice coefficient with a 1.5 tolerance and UPGMA cluster.

Seven unique MLVA profiles and 12 unique PFGE (AscI and ApaI) profiles were detected among the 31 isolates of serotypes 1/2b and 3b, based on nine epidemiological groups and three unlinked isolates (Fig. 4). As described above, several PFGE profiles differed by only one to two bands. The isolates from the gastroenteritis outbreak in Italy (Table 1) were found to have identical MLVA and PFGE profiles. This MLVA profile was also found in three other isolates from the United States and the United Kingdom (Fig. 4, filled squares). The ApaI patterns for these isolates were also identical; however, differences were seen in the AscI pattern for the United Kingdom isolate. The chocolate milk outbreak isolates (Table 1; Fig. 4, indicated by an arrow) were also identical by both PFGE and MLVA.

FIG. 4.

FIG. 4.

Cluster analysis of 31 L. monocytogenes serotype 1/2b and 3b isolates. Symbols next to isolate names indicate similar isolates in MLVA and PFGE dendrograms. If isolates have indistinguishable patterns, then they are listed with one representative pattern. (A) Results of MLVA typing using the categorical coefficient and UPGMA. (B) Results of two-enzyme PFGE analysis (AscI and ApaI). The average from experiments was used to cluster the similarity matrix determined by single-enzyme analysis using the Dice coefficient with a 1.5 tolerance and UPGMA cluster.

Comparisons of 60 serotype 4b isolates showed the most significant differences between MLVA and PFGE (AscI and ApaI) (Fig. 5). Nine unique MLVA profiles and 26 unique PFGE (AscI and ApaI) profiles were produced based on cluster analysis of these isolates. The MLVA clearly separated the sporadic isolates from outbreak isolates. The MLVA was also able to group isolates by epidemic clone groups. Analyses based on unique genomic markers, gene cassettes, and single nucleotide polymorphisms have also found similarities between the strains associated with the epidemic clone groups (21, 23, 33, 34, 54-56). In efforts to increase the subtyping ability of this MLVA for L. monocytogenes, six loci (Lm-38 to Lm-43) were designed specifically for serotype 4b. Two of these loci had very low diversity, and one had variability in the flanking region. The remaining three loci did not affect the subtyping ability, clustering the 4b isolates identically as the panel of eight loci used in the multiplexed assay (Table 3).

FIG. 5.

FIG. 5.

Cluster analysis of 60 L. monocytogenes serotype 4b isolates. Symbols next to isolate names indicate similar isolates in MLVA and PFGE dendrograms. If isolates have indistinguishable patterns, then they are listed with one representative pattern. EC groups are indicated as follows: ▪, ECI; •, ECII. (A) Results of MLVA typing using the categorical coefficient and UPGMA. (B) Results of two-enzyme PFGE analysis (AscI and ApaI). The average from experiments was used to cluster the similarity matrix determined by single-enzyme analysis using the Dice coefficient with a 1.5 tolerance and UPGMA cluster.

Comparisons were made between the serotype 4b MLVA results and previously published work with multilocus genotyping (MLGT) (21) and multivirulence locus sequence typing (MVLST) (56). The ECI isolates grouped together in three main clusters, differing by only one locus, using MLVA (Fig. 5A, filled squares). The epidemic groups (EG) from the WHO multicenter study (6) are used here simply to denote epidemiological information (Table 1). EG-9, -13, -15, -16, -18, and -21 and EG-12 and -17 were identical by MLVA. PFGE clustering of EG-9, -15, -16, -17, and -18 showed identical AscI patterns and closely related ApaI patterns. EG-12 and EG-16 were identical, except for isolate G4021, which matched EG-9. PFGE did not cluster all isolates from EG-13 together nor did it cluster all isolates from EG-21 together (Fig. 5B, filled squares). MVLST clustered EG-12, -13, and -16 as identical to one another (56). MLGT clustered EG-12, -13, and -16 as similar although some differences were seen between the outbreaks (21). ECII isolates were not represented in the WHO multicenter study (6) since the ECII strain type was not identified until the multistate hotdog outbreak of 1998 to 1999 (13, 14, 23). ECII isolates grouped together into four clusters differing by one locus using MLVA (Fig. 5A, filled circles). As described previously, PFGE of these isolates with AscI produced two distinct patterns and PFGE with ApaI produced four closely related patterns (Fig. 5, filled circles) (31). These clusters correlated well with those identified by MLVA. The ECII isolates also clustered as identical by MVLST (15). In future studies, MLVA results could be more thoroughly compared to those of MVLST and MLGT by including additional isolates and serotypes.

In conclusion, this study details the development of an MLVA method for L. monocytogenes that consists of two multiplexed PCRs. The loci were selected based on their ability to subtype primarily serotypes 1/2a, 1/2b, and 4b. All of the loci selected have relatively small repeat units of 6 bp to 15 bp. The MLVA is a high-throughput, rapid assay with much improved data portability compared to PFGE. The most notable advantage of the MLVA is the lack of subjectivity. While PFGE relies on stringent adherence to subjective band-marking procedures, MLVA generates exact fragment sizes that are directly imported into BioNumerics. This allows the data transfer and interlaboratory comparison to be seamless. An added benefit for PulseNet laboratories is that different food-borne organisms (e.g., E. coli, S. enterica serotype Typhimurium, and L. monocytogenes) can be analyzed simultaneously using capillary gel electrophoresis. These advantages make MLVA an ideal choice for the next generation of food-borne subtyping tests in public health laboratories.

Acknowledgments

This study was part of the PulseNet USA initiative for the development of the next generation of subtyping methods.

This work was supported by Grant Cooperative Agreement Number U60-CCU303019 from the CDC and APHL. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of APHL or CDC.

We gratefully acknowledge Denise Griffin, Shadia Barghothi, Debra Springer, and Memory Dalton, NCSLPH PulseNet Team, for PFGE data and isolate preparation; Robin Siletzky, North Carolina State University, for her technical expertise, strain preparation, strain typing, and assistance in accumulating epidemiological information; Lewis Graves, CDC, for providing isolates and epidemiological and serotype information as well as scientific discussion; PulseNet, National Database Team, for PFGE data; Shari Shea, APHL, for assistance with administration of the contract; Bala Swaminathan and Eija Trees, CDC, for scientific discussion; North Carolina Department of Agriculture and Consumer Services for submission of isolates; and Shermalyn Greene and Rachel Gast, NCSLPH, for their scientific discussion and critical review of the manuscript.

Footnotes

Published ahead of print on 6 February 2008.

REFERENCES

  • 1.Azadian, B. S., and G. T. Finnerty. 1989. Cheese-borne listeria meningitis in immunocompetent patient. Lancet 1322-323. [DOI] [PubMed] [Google Scholar]
  • 2.Bannister, B. A. 1987. Listeria monocytogenes meningitis associated with eating soft cheese. J. Infect. 15165-168. [DOI] [PubMed] [Google Scholar]
  • 3.Barnes, R., P. Archer, J. Strack, and G. R. Istre. 1989. Listeriosis associated with consumption of turkey franks. MMWR Morb. Mortal. Wkly. Rep. 38267-268. [PubMed] [Google Scholar]
  • 4.Benson, G. 1999. Tandem repeats finder: a program to analyze DNA sequences. Nucleic Acids Res. 27573-580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Bille, J. 1990. Epidemiology of human listeriosis in Europe with special reference to the Swiss outbreak, p. 71-74. In A. J. Miller, J. L. Smith, and G. A. Somkuti (ed.), Foodborne listeriosis. Elsevier, Amsterdam, The Netherlands.
  • 6.Bille, J., and J. Rocourt. 1996. WHO International Multicenter Listeria monocytogenes subtyping study—rationale and set-up of the study. Int. J. Food Microbiol. 32251-262. [DOI] [PubMed] [Google Scholar]
  • 7.Bille, J., J. Rocourt, and B. Swaminathan. 2003. Listeria and Erysipelothrix, p. 461-471. In P. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.), Manual of clinical microbiology, 8th ed., vol. 1. ASM Press, Washington, DC. [Google Scholar]
  • 8.Borucki, M. K., J. Reynolds, D. R. Call, T. J. Ward, B. Page, and J. Kadushin. 2005. Suspension microarray with dendrimer signal amplification allows direct and high-throughput subtyping of Listeria monocytogenes from genomic DNA. J. Clin. Microbiol. 433255-3259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Boxrud, D., K. Pederson-Gulrud, J. Wotton, C. Medus, E. Lyszkowicz, J. Besser, and J. M. Bartkus. 2007. Comparison of multiple-locus variable-number tandem-repeat analysis, pulsed-field gel electrophoresis, and phage typing for subtype analysis of Salmonella enterica serotype Enteritidis. J. Clin. Microbiol. 45536-543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Brosch, R., M. Brett, B. Catimel, J. B. Luchansky, B. Ojeniyi, and J. Rocourt. 1996. Genomic fingerprinting of 80 strains from the WHO multicenter international typing study of Listeria monocytogenes via pulsed-field gel electrophoresis (PFGE). Int. J. Food Microbiol. 32343-355. [DOI] [PubMed] [Google Scholar]
  • 11.Buchrieser, C., R. Brosch, B. Catimel, and J. Rocourt. 1993. Pulsed-field gel electrophoresis applied for comparing Listeria monocytogenes strains involved in outbreaks. Can. J. Microbiol. 39395-401. [DOI] [PubMed] [Google Scholar]
  • 12.Carbonnelle, B., J. Cottin, F. Parvery, G. Chambreuil, S. Kouyoumdjian, M. L. Lirzin, G. Cordier, and F. Vincent. 1979. Epidemic of listeriosis in Western France (1975-1976). Rev. Epidemiol. Sante Publique 26451-467. [PubMed] [Google Scholar]
  • 13.Centers for Disease Control and Prevention. 1998. Multistate outbreak of listeriosis—United States, 1998. MMWR Morb. Mortal. Wkly. Rep. 471085-1086. [PubMed] [Google Scholar]
  • 14.Centers for Disease Control and Prevention. 1999. Update: multistate outbreak of listeriosis—United States, 1998-1999. MMWR Morb. Mortal. Wkly. Rep. 471117-1118. [PubMed] [Google Scholar]
  • 15.Chen, Y., W. Zhang, and S. J. Knabel. 2007. Multi-virulence-locus sequence typing identifies single nucleotide polymorphisms which differentiate epidemic clones and outbreak strains of Listeria monocytogenes. J. Clin. Microbiol. 45835-846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Dalton, C. B., C. C. Austin, J. Sobel, P. S. Hayes, W. F. Bibb, L. M. Graves, B. Swaminathan, M. E. Proctor, and P. M. Griffin. 1997. An Outbreak of gastroenteritis and fever due to Listeria monocytogenes in milk. N. Engl. J. Med. 336100-106. [DOI] [PubMed] [Google Scholar]
  • 17.De Cesare, A., J. L. Bruce, T. R. Dambaugh, M. E. Guerzoni, and M. Wiedmann. 2001. Automated ribotyping using different enzymes to improve discrimination of Listeria monocytogenes isolates, with a particular focus on serotype 4b strains. J. Clin. Microbiol. 393002-3005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Denoeud, F., and G. Vergnaud. 2004. Identification of polymorphic tandem repeats by direct comparison of genome sequence from different bacterial strains: a web-based resource. BMC Bioinform. 54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Denoeud, F., G. Vergnaud, and G. Benson. 2003. Predicting human minisatellite polymorphism. Genome Res. 13856-867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Doumith, M., C. Buchrieser, P. Glaser, C. Jacquet, and P. Martin. 2004. Differentiation of the major Listeria monocytogenes serovars by multiplex PCR. J. Clin. Microbiol. 423819-3822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Ducey, T. F., B. Page, T. Usgaard, M. K. Borucki, K. Pupedis, and T. J. Ward. 2007. A single-nucleotide-polymorphism-based multilocus genotyping assay for subtyping lineage I isolates of Listeria monocytogenes. Appl. Environ. Microbiol. 73133-147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Eifert, J. D., P. A. Curtis, M. C. Bazaco, R. J. Meinersmann, M. E. Berrang, S. Kernodle, C. Stam, L. A. Jaykus, and S. Kathariou. 2005. Molecular characterization of Listeria monocytogenes of the serotype 4b complex (4b, 4d, 4e) from two turkey processing plants. Foodborne Pathog. Dis. 2192-200. [DOI] [PubMed] [Google Scholar]
  • 23.Evans, M. R., B. Swaminathan, L. M. Graves, E. Altermann, T. R. Klaenhammer, R. C. Fink, S. Kernodle, and S. Kathariou. 2004. Genetic markers unique to Listeria monocytogenes serotype 4b differentiate epidemic clone II (hot dog outbreak strains) from other lineages. Appl. Environ. Microbiol. 702383-2390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Farber, J. M., A. O. Carter, P. V. Varughese, F. E. Ashton, and E. P. Ewan. 1990. Listeriosis traced to the consumption of alfalfa tablets and soft cheese. N. Engl. J. Med. 322338. [DOI] [PubMed] [Google Scholar]
  • 25.Farlow, J., K. L. Smith, J. Wong, M. Abrams, M. Lytle, and P. Keim. 2001. Francisella tularensis strain typing using multiple-locus, variable-number tandem-repeat analysis. J. Clin. Microbiol. 393186-3192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Fleming, D. W., S. L. Cochi, K. L. MacDonald, J. Brondum, P. S. Hayes, B. D., M. B. Holmes, A. Audurier, C. V. Broome, and A. L. Reingold. 1985. Pasteurized milk as a vehicle of infection in an outbreak of listeriosis. N. Engl. J. Med. 312404-407. [DOI] [PubMed] [Google Scholar]
  • 27.Fugett, E., E. Fortes, C. Nnoka, and M. Wiedmann. 2006. International Life Sciences Institute North America Listeria monocytogenes strain collection: development of standard Listeria monocytogenes strain sets for research and validation studies. J. Food Prot. 692929-2938. [DOI] [PubMed] [Google Scholar]
  • 28.Gerner-Smidt, P., K. Hise, J. Kincaid, S Hunter, S. Rolando, E. Hyytiä-Trees, E. M. Ribot, B. Swaminathan, and the Pulsenet Taskforce. 2006. PulseNet USA: a five-year update. Foodborne Pathog. Dis. 39-19. [DOI] [PubMed] [Google Scholar]
  • 29.Glaser, P., L. Frangeul, C. Buchrieser, C. Rusniok, A. Amend, F. Baquero, P. Berche, H. Bloecker, P. Brandt, T. Chakraborty, A. Charbit, F. Chetouani, E. Couve, A. de Daruvar, P. Dehoux, E. Domann, G. Dominguez-Bernal, E. Duchaud, L. Durant, O. Dussurget, K. D. Entian, H. Fsihi, F. G.-D. Portillo, P. Garrido, L. Gautier, W. Goebel, N. Gomez-Lopez, T. Hain, J. Hauf, D. Jackson, L. M. Jones, U. Kaerst, J. Kreft, M. Kuhn, F. Kunst, G. Kurapkat, E. Madueno, A. Maitournam, J. M. Vicente, E. Ng, H. Nedjari, G. Nordsiek, S. Novella, B. de Pablos, J. C. Perez-Diaz, R. Purcell, B. Remmel, M. Rose, T. Schlueter, N. Simoes, A. Tierrez, J. A. Vazquez-Boland, H. Voss, J. Wehland, and P. Cossart. 2001. Comparative genomics of Listeria species. Science 294849-852. [DOI] [PubMed] [Google Scholar]
  • 30.Gottlieb, S. L., E. C. Newbern, P. M. Griffin, L. M. Graves, R. M. Hoekstra, N. L. Baker, S. B. Hunter, K. G. Holt, F. Ramsey, M. Head, P. Levine, G. Johnson, D. Schoonmaker-Bopp, V. Reddy, L. Kornstein, M. Gerwel, J. Nsubuga, L. Edwards, S. Stonecipher, S. Hurd, D. Austin, M. A. Jefferson, S. D. Young, K. Hise, E. D. Chernak, J. Sobel, and the Listeriosis Outbreak Working Group. 2006. Multistate outbreak of listeriosis linked to turkey deli meat and subsequent changes in US regulatory policy. Clin. Infect. Dis. 4229-36. [DOI] [PubMed] [Google Scholar]
  • 31.Graves, L. M., S. B. Hunter, A. R. Ong, D. Schoonmaker-Bopp, K. Hise, L. Kornstein, W. E. DeWitt, P. S. Hayes, E. Dunne, P. Mead, and B. Swaminathan. 2005. Microbiological aspects of the investigation that traced the 1998 outbreak of listeriosis in the United States to contaminated hot dogs and establishment of molecular subtyping-based surveillance for Listeria monocytogenes in the PulseNet network. J. Clin. Microbiol. 432350-2355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Graves, L. M., and S. B. 2001. PulseNet standardized protocol for subtyping Listeria monocytogenes by macrorestriction and pulsed-field gel electrophoresis. Int. J. Food Microbiol. 6555-62. [DOI] [PubMed] [Google Scholar]
  • 33.Herd, M., and C. Kocks. 2001. Gene fragments distinguishing an epidemic-associated strain from a virulent prototype strain of Listeria monocytogenes belong to a distinct functional subset of genes and partially cross-hybridize with other Listeria species. Infect. Immun. 693972-3979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Kathariou, S., L. Graves, C. Buchrieser, P. Glaser, R. M. Siletzky, and B. Swaminathan. 2006. Involvement of closely related strains of a new clonal group of Listeria monocytogenes in the 1998-99 and 2002 multistate outbreaks of foodborne listeriosis in the United States. Foodborne Pathog. Dis. 3292-302. [DOI] [PubMed] [Google Scholar]
  • 35.Keim, P., L. B. Price, A. M. Klevytska, K. L. Smith, J. M. Schupp, R. Okinaka, P. J. Jackson, and M. E. Hugh-Jones. 2000. Multiple-locus variable-number tandem-repeat analysis reveals genetic relationships within Bacillus anthracis. J. Bacteriol. 1822928-2936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Keys, C., S. Kemper, and P. Keim. 2005. Highly diverse variable number tandem repeat loci in the E. coli O157:H7 and O55:H7 genomes for high-resolution molecular typing. J. Appl. Microbiol. 98928-940. [DOI] [PubMed] [Google Scholar]
  • 37.Linnan, M. J., L. Mascola, X. D. Lou, V. Goulet, S. May, C. Salminen, D. W. Hird, M. L. Yonekura, P. Hayes, R. Weaver, A. Audurier, B. D. Plikaytis, S. L. Fannin, A. Kleks, and C. V. Broome. 1988. Epidemic listeriosis associated with Mexican-style cheese. N. Engl. J. Med. 319823-828. [DOI] [PubMed] [Google Scholar]
  • 38.McLauchlin, J., A. Audurier, and A. G. Taylor. 1986. Aspects of the epidemiology of human Listeria monocytogenes infections in Britain 1967-1984: the use of serotyping and phage typing. J. Med. Microbiol. 22367-377. [DOI] [PubMed] [Google Scholar]
  • 39.McLauchlin, J., S. M. Hall, S. K. Velani, and R. J. Gilbert. 1991. Human listeriosis and paté: a possible association. Br. Med. J. 303773-775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Murphy, M., D. Cocoran, J. Buckley, M. O'Mahony, P. Whyte, and S. Fanning. 2007. Development and application of multiple locus variable number tandem repeat analysis to subtype a collection of Listeria monocytogenes. Int. J. Food Microbiol. 115187-194. [DOI] [PubMed] [Google Scholar]
  • 41.Nelson, K. E., D. E. Fouts, E. F. Mongodin, J. Ravel, R. T. DeBoy, J. F. Kolonay, D. A. Rasko, S. V. Angiuoli, S. R. Gill, I. T. Paulsen, J. Peterson, O. White, W. C. Nelson, W. Nierman, M. J. Beanan, L. M. Brinkac, S. C. Daugherty, R. J. Dodson, A. S. Durkin, R. Madupu, D. H. Haft, J. Selengut, S. Van Aken, H. Khouri, N. Fedorova, H. Forberger, B. Tran, S. Kathariou, L. D. Wonderling, G. A. Uhlich, D. O. Bayles, J. B. Luchansky, and C. M. Fraser. 2004. Whole genome comparisons of serotype 4b and 1/2a strains of the food-borne pathogen Listeria monocytogenes reveal new insights into the core genome components of this species. Nucleic Acids Res. 322386-2395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Olsen, S. J., M. Patrick, S. B. Hunter, V. Reddy, L. Kornstein, W. R. MacKenzie, K. Lane, S. Bidol, G. A. Stoltman, D. M. Frye, I. Lee, S. Hurd, T. F. Jones, T. N. LaPorte, W. Dewitt, L. Graves, M. Wiedmann, D. J. Schoonmaker-Bopp, A. J. Huang, C. Vincent, A. Bugenhagen, J. Corby, E. R. Carloni, M. E. Holcomb, R. F. Woron, S. M. Zansky, G. Dowdle, F. Smith, S. Ahrabi-Fard, A. R. Ong, N. Tucker, N. A. Hynes, and P. Mead. 2005. Multistate outbreak of Listeria monocytogenes infection linked to delicatessen turkey meat. Clin. Infect. Dis. 40962-967. [DOI] [PubMed] [Google Scholar]
  • 43.Pinner, R. W., A. Schuchat, B. Swaminathan, P. S. Hayes, K. A. Deaver, R. E. Weaver, B. D. Plikaytis, M. Reeves, C. V. Broome, J. D. Wenger, et al. 1992. Role of foods in sporadic listeriosis. II. Microbiologic and epidemiologic investigation. JAMA 2672046-2050. [PubMed] [Google Scholar]
  • 44.Revazishvili, T., M. Kotetishvili, O. C. Stine, A. S. Kreger, J. G. Morris, Jr., and A. Sulakvelidze. 2004. Comparative analysis of multilocus sequence typing and pulsed-field gel electrophoresis for characterizing Listeria monocytogenes strains isolated from environmental and clinical sources. J. Clin. Microbiol. 42276-285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Rozen, S., and H. J. Skaletsky. 2000. Primer3 on the WWW for general users and for biologist programmers. Humana Press, Totowa, NJ. [DOI] [PubMed]
  • 46.Salamina, G., E. Dalle Donne, A. Niccolini, G. Poda, D. Cesaroni, M. Bucci, R. Fini, M. Maldini, A. Schuchat, B. Swaminathan, W. Bibb, J. Rocourt, N. Binkin, and S. Salmaso. 1996. A foodborne outbreak of gastroenteritis involving Listeria monocytogenes. Epidemiol. Infect. 117429-436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Schlech, W. F., P. M. Lavigne, R. A. Bortolussi, A. C. Allen, E. V. Haldane, A. J. Wort, A. W. Hightower, S. E. Johnson, S. H. King, E. S. Nicholls, and C. V. Broome. 1983. Epidemic listeriosis—evidence for transmission by food. N. Engl. J. Med. 308203-206. [DOI] [PubMed] [Google Scholar]
  • 48.Schuchat, A., B. Swaminathan, and C. V. Broome. 1991. Epidemiology of human listeriosis. Clin. Microbiol. Rev. 4169-183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Simpson, E. H. 1949. Measurement of diversity. Nature 163688. [Google Scholar]
  • 50.Swaminathan, B., T. J. Barrett, S. B. Hunter, R. V. Taux, and T. C. P. T. Force. 2001. PulseNet: the molecular subtyping network for foodborne bacterial disease surveillance, United States. Emerg. Infect. Dis. 7382-389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.van Belkum, A. 1999. Short sequence repeats in microbial pathogenesis and evolution. Cell. Mol. Life Sci. 56729-734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Vergnaud, G., and F. Denoeud. 2000. Minisatellites: mutability and genome architecture. Genome Res. 10899-907. [DOI] [PubMed] [Google Scholar]
  • 53.Wenger, J. D., B. Swaminathan, P. S. Hayes, S. S. Green, M. Pratt, R. W. Pinner, A. Schuchat, and C. V. Broome. 1990. Listeria monocytogenes contamination of turkey franks: evaluation of a production facility. J. Food Prot. 531015-1019. [DOI] [PubMed] [Google Scholar]
  • 54.Yildirim, S., W. Lin, A. D. Hitchins, L.-A. Jaykus, E. Altermann, T. R. Klaenhammer, and S. Kathariou. 2004. Epidemic clone I-specific genetic markers in strains of Listeria monocytogenes serotype 4b from foods. Appl. Environ. Microbiol. 704158-4164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Zhang, C., M. Zhang, J. Ju, J. Nietfeldt, J. Wise, P. M. Terry, M. Olson, S. D. Kachman, M. Wiedmann, M. Samadpour, and A. K. Benson. 2003. Genome diversification in phylogenetic lineages I and II of Listeria monocytogenes: identification of segments unique to lineage II populations. J. Bacteriol. 1855573-5584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Zhang, W., B. M. Jayarao, and S. J. Knabel. 2004. Multi-virulence-locus sequence typing of Listeria monocytogenes. Appl. Environ. Microbiol. 70913-920. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES